Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Net Income: 2009-2024

Historic Net Income for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • UNITED THERAPEUTICS's Net Income rose 9.58% to $338.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 14.47%. This contributed to the annual value of $1.2 billion for FY2024, which is 21.35% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Net Income stood at $1.2 billion for FY2024, which was up 21.35% from $984.8 million recorded in FY2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Net Income peaked at $1.2 billion during FY2024, and registered a low of $475.8 million during FY2021.
  • In the last 3 years, UNITED THERAPEUTICS's Net Income had a median value of $984.8 million in 2023 and averaged $969.1 million.
  • In the last 5 years, UNITED THERAPEUTICS's Net Income spiked by 592.63% in 2020 and then declined by 7.58% in 2021.
  • UNITED THERAPEUTICS's Net Income (Yearly) stood at $514.8 million in 2020, then declined by 7.58% to $475.8 million in 2021, then soared by 52.86% to $727.3 million in 2022, then surged by 35.40% to $984.8 million in 2023, then increased by 21.35% to $1.2 billion in 2024.